Caixin
Aug 24, 2022 08:00 AM

Zhejiang Cheng Yi Pharmaceutical Co.,Ltd.’s Net Profit Dropped 17.5% in First Half of 2022

Zhejiang Cheng Yi Pharmaceutical Co.,Ltd. (浙江诚意药业股份有限公司) (603811.SH) reported a net profit of 64.9 million yuan in the first half of 2022, down 17.5% year-on-year.

Meanwhile, the company posted 318.2 million yuan in revenue, down 11.1% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 542.2 million yuan in total liabilities, with a liability-to-asset ratio of 35.3%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’
00:00
00:00/00:00